001442866 000__ 04728cam\a2200565\i\4500
001442866 001__ 1442866
001442866 003__ OCoLC
001442866 005__ 20230310003439.0
001442866 006__ m\\\\\o\\d\\\\\\\\
001442866 007__ cr\un\nnnunnun
001442866 008__ 211130s2022\\\\sz\a\\\\o\\\\\000\0\eng\d
001442866 019__ $$a1286709861$$a1286791224$$a1287138549$$a1294366471$$a1296666997
001442866 020__ $$a9783030812614$$q(electronic bk.)
001442866 020__ $$a3030812618$$q(electronic bk.)
001442866 020__ $$z9783030812607
001442866 020__ $$z303081260X
001442866 0247_ $$a10.1007/978-3-030-81261-4$$2doi
001442866 035__ $$aSP(OCoLC)1286665319
001442866 040__ $$aYDX$$beng$$erda$$epn$$cYDX$$dGW5XE$$dEBLCP$$dOCLCF$$dOCLCO$$dDCT$$dDKU$$dN$T$$dAUD$$dOCLCO$$dOCLCQ
001442866 049__ $$aISEA
001442866 050_4 $$aR895$$b.N83 2022
001442866 08204 $$a616.07/575$$223
001442866 24500 $$aNuclear medicine and immunology /$$cSara Harsini, Abass Alavi, Nima Rezaei, editors.
001442866 264_1 $$aCham :$$bSpringer,$$c[2022]
001442866 264_4 $$c©2022
001442866 300__ $$a1 online resource :$$billustrations (chiefly color)
001442866 336__ $$atext$$btxt$$2rdacontent
001442866 337__ $$acomputer$$bc$$2rdamedia
001442866 338__ $$aonline resource$$bcr$$2rdacarrier
001442866 347__ $$atext file
001442866 347__ $$bPDF
001442866 5050_ $$a1. Molecular Imaging in Inflammatory and Autoimmune Disorders -- 2. Gallium Imaging of Infection and Inflammation -- 3. 111Indium-Labeled Leukocyte Imaging of Infection and Inflammation -- 4. 99mTc-HMPAO-Labeled-Leukocyte Imaging of Infection and Inflammation -- 5. FDG-PET Imaging of Infection and Inflammation -- 6. Imaging Procedures with Radiolabeled Monoclonal Antibodies -- 7. Dosimetric Principles of Targeted Radiotherapy -- 8. Radioimmunotherapy (RIT) -- 9. Peptide Receptor Radionuclide Therapy (PRRT) -- 10. Tumor Architecture and Targeted Delivery -- 11. Antibodies and Novel Constructs for Tumor Targeting -- 12. Pretargeted Radioimmunotherapy of Cancer -- 13. Radioimmunotherapy of Lymphoma -- 14. Radioimmunotherapy in Brain Tumors -- 15. Radioimmunotherapy of Pancreatic Adenocarcinoma -- 16. Radioimmunotherapy of Renal Cell Carcinoma -- 17. Radioimmunotherapy of Prostate Carcinoma -- 18. Radioimmunotherapy of Ovarian Cancer -- 19. Targeted Radiotherapy in the Treatment of Osteosarcoma -- 20. Targeted Radiotherapy of Neuroblastoma -- 21. Targeted Radiotherapy of Squamous Cell Carcinoma of the Head and Neck -- 22. Moving Forward: Expected Opportunities for the Development of New Therapeutic Agents -- 23. Translation of Radiopharmaceuticals from Bench to Bedside.
001442866 506__ $$aAccess limited to authorized users.
001442866 520__ $$aThis book explores the close connection between immunology and nuclear medicine, which has led to radioimmunoimaging and radioimmunotherapy (RIT). Molecular imaging with positron emission tomography (PET) and single-photon emission computed tomography (SPECT) is increasingly being used to diagnose, characterize, and monitor disease activity in the context of inflammatory disorders of known and unknown etiology, such as sarcoidosis, atherosclerosis, vasculitis, inflammatory bowel disease, rheumatoid arthritis, and degenerative joint disease. The first chapters discuss the various radiopharmaceutical agents and radiolabeled preparations that have been employed in inflammation imaging. Of these, FDG-PET imaging has been shown to have the great value in the detection of inflammation and has become the centerpiece of several initiatives over the last several years. This very powerful technique will play an increasingly important role in the management of patients with inflammatory conditions in the future. The book also explores the growing role of nuclear medicine and molecular imaging in the diagnosis and treatment of cancer. The rapid pace of change has been fueled by advances in our understanding of tumor biology, on the one hand, and the development of specifically targeted medical therapies, diagnostic agents, and radiotherapies, on the other. Written by leading international experts in the field, this book is an invaluable tool for nuclear medicine physicians, radiologists, oncologists, and immunologists.
001442866 588__ $$aOnline resource; title from PDF title page (SpringerLink, viewed December 8, 2021).
001442866 650_0 $$aNuclear medicine.
001442866 650_0 $$aImmunology.
001442866 650_6 $$aMédecine nucléaire.
001442866 650_6 $$aImmunologie.
001442866 655_0 $$aElectronic books.
001442866 7001_ $$aHarsini, Sara,$$eeditor.
001442866 7001_ $$aAlavi, Abass,$$eeditor.
001442866 7001_ $$aRezaei, Nima,$$eeditor.
001442866 77608 $$iPrint version:$$z303081260X$$z9783030812607$$w(OCoLC)1257402676
001442866 852__ $$bebk
001442866 85640 $$3Springer Nature$$uhttps://univsouthin.idm.oclc.org/login?url=https://link.springer.com/10.1007/978-3-030-81261-4$$zOnline Access$$91397441.1
001442866 909CO $$ooai:library.usi.edu:1442866$$pGLOBAL_SET
001442866 980__ $$aBIB
001442866 980__ $$aEBOOK
001442866 982__ $$aEbook
001442866 983__ $$aOnline
001442866 994__ $$a92$$bISE